HCID 67003892, compound → HCID 67003637, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([NH:31][C:32](=[O:37])[CH2:33][N:34]([CH3:36])[CH3:35])[CH:5]=[CH:6][C:7]=1[C:8]1[NH:30][C:11]2=[N:12][CH:13]=[C:14]([Cl:29])[C:15]([C:16]3[S:20][C:19]([C:21]4([O:25]COC)[CH2:24][CH2:23][CH2:22]4)=[N:18][CH:17]=3)=[C:10]2[CH:9]=1.ClC1C(C2SC(C3(OCOC)CCC3)=NC=2)=C2C=C(C3N=C(C4CCCN(C(OC(C)(C)C)=O)C4)ON=3)NC2=NC=1>>[Cl:1][C:2]1[CH:3]=[C:4]([NH:31][C:32](=[O:37])[CH2:33][N:34]([CH3:35])[CH3:36])[CH:5]=[CH:6][C:7]=1[C:8]1[NH:30][C:11]2=[N:12][CH:13]=[C:14]([Cl:29])[C:15]([C:16]3[S:20][C:19]([C:21]4([OH:25])[CH2:24][CH2:23][CH2:22]4)=[N:18][CH:17]=3)=[C:10]2[CH:9]=1Participants
3
Procedure
The title compound was prepared as described in Example 22E, substituting N-(3-chloro-4-(5-chloro-4-(2-(1-(methoxymethoxy)cyclobutyl)thiazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl)phenyl)-2-(dimethylamino)acetamide (Example 61C) for 1 tert-butyl 3-(3-(5-chloro-4-(2-(1-(methoxymethoxy)cyclobutyl)thiazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl)-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate (Example 22D). 1H NMR (400 MHz, DMSO-d6) ppm 12.45 (s, 1H) 10.10 (s, 1H) 8.38 (s, 1H) 8.23 (s, 1H) 8.06 (d, 1H) 7.73 (m, 2H) 6.89 (s, 1H) 6.68 (s, 1H) 3.12 (s, 2H) 2.61 (m, 2H) 2.40 (m, 2H) 2.29 (s, 6H) 1.97 (m, 2H); MS ESI(+) m/z 518.0 [M+H]+.
Sources & evidence
- ORD record
- ord-2c7cccbc91aa4942a14bf663a7ba9d60
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08691810B2
Reaction notes
Loading…